Adult Hodgkin's Lymphoma |
|
|
Clinical Trial: Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
This study is currently recruiting patients.
|
Purpose
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies such as rituximab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether combination chemotherapy is more effective with or without rituximab in treating aggressive non-Hodgkin's lymphoma.
PURPOSE: Randomized phase III trial to compare the effectiveness of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without rituximab in treating older patients who have aggressive non-Hodgkin's lymphoma.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| adult T-cell leukemia and lymphoma anaplastic large cell lymphoma angioimmunoblastic T-cell lymphoma Non-Hodgkin's Lymphoma | Drug: cyclophosphamide Drug: doxorubicin Drug: filgrastim Drug: prednisone Drug: rituximab Drug: vincristine Procedure: antibody therapy Procedure: biological response modifier therapy Procedure: chemotherapy Procedure: colony-stimulating factor therapy Procedure: cytokine therapy Procedure: monoclonal antibody therapy Procedure: radiation therapy | Phase III |
MedlinePlus related topics: Cancer; Cancer Alternative Therapy; Immune System and Disorders; Leukemia, Adult Acute; Leukemia, Adult Chronic; Leukemia, Childhood; Lymphatic Diseases; Lymphoma; Viral Infections
Study Type: Interventional
Study Design: Treatment
Official Title: Phase III Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Rituximab in Elderly Patients With Aggressive Non-Hodgkin's Lymphoma
OBJECTIVES:
- Compare the efficacy of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without rituximab in elderly patients with aggressive non-Hodgkin's lymphoma.
- Compare the rate of complete remission, rate of primary progression, tumor control, disease-free survival, overall survival, and relapse after radiotherapy in patients treated with these regimens.
- Compare the safety and side effects of these regimens in these patients.
OUTLINE: This is a randomized, open-label, multicenter study. Patients are stratified according to participating center, value for serum lactic dehydrogenase (no greater than upper limit of normal [ULN] vs greater than ULN), bulky disease present (no vs yes), stage (I or II vs III or IV), general ECOG status of patient (0 or 1 vs 2), and age (61 to 70 vs 71-80). Patients are randomized to 1 of 4 treatment arms. Patients with CD20-negative lymphoma are randomized to arms I or II only.
- Prephase treatment:Patients receive vincristine IV on day -6 and prednisone on day -6 to day 0 before initiating CHOP chemotherapy.
- Arm I: Patients receive standard CHOP chemotherapy comprising cyclophosphamide IV, doxorubicin IV, and vincristine IV on day 1 and oral prednisone on days 1-5. Patients also receive filgrastim (G-CSF) subcutaneously once daily on days 6-12 of each CHOP course. Treatment repeats every 2 weeks for 6 courses.
- Arm II: Patients receive standard CHOP chemotherapy and G-CSF as in arm I for a total of 8 courses.
- Arm III: Patients receive standard CHOP chemotherapy and G-CSF as in arm I. Patients also receive rituximab IV before CHOP every 2 weeks for a total of 8 courses.
- Arm IV: Patients receive standard CHOP chemotherapy and G-CSF as in arm II. Patients also receive rituximab IV before CHOP every 2 weeks for a total of 8 courses. In all arms, treatment continues in the absence of disease progression or unacceptable toxicity.
Beginning 3-6 weeks after completion of the last chemotherapy course, after complete recovery of bone marrow, and after complete remision of mucositis, patients with sites of initial bulky disease or extranodal involvement undergo radiotherapy 5 times a week for 4 weeks.
Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
PROJECTED ACCRUAL: Approximately 880 patients (220 per treatment arm) will be accrued for this study within 5 years.
Eligibility
Ages Eligible for Study: 61 Years - 80 Years, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- Histologically confirmed aggressive non-Hodgkin's lymphoma (NHL) by an excisional biopsy of a lymph node or an extensive biopsy of an extranodal involvement (if there is no lymph node involvement)
- CD20^+ B-cell lymphoma or CD20^- B-cell and T-cell lymphoma allowed
- B-cell NHL including the following:
- Stage III follicular lymphoma
- Stage III follicular lymphoma and diffuse B-cell lymphoma
- Lymphoblastic precursor B-cell lymphoma
- Diffuse large cell B-cell lymphoma
- Centroblastic
- Immunoblastic
- Plasmablastic
- Anaplastic large cell
- T-cell-rich B-cell lymphoma
- Primary effusion lymphoma
- Intravasal B-cell lymphoma
- Primary mediastinal B-cell lymphoma
- Mantle zone lymphoma, blastoid
- Burkitt's lymphoma
- Burkitt-like lymphoma
- Aggressive marginal zone lymphoma (monocytoid)
- T-cell NHL including the following:
- Lymphoblastic precursor T-cell lymphoma
- Peripheral T-cell lymphoma (PTCL) not otherwise specified (NOS)
- Lennert's lymphoma
- T-zone lymphoma
- T-cell lymphoma of the angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) type
- Anaplastic large cell lymphoma
- ALK^+
- ALK^-
- Extranodal NK/T-cell lymphoma, nasal type
- Intestinal T/NK-cell lymphoma (with or without enteropathy)
- Hepatosplenic gamma-delta lymphoma
- Subcutaneous panniculitis-like PTCL
- Aggressive T/NK PTCL
- Anaplastic large-cell NHL, NOS
- Bone marrow involvement no more than 25%
- No lymphoma that is clearly restricted to the CNS or originating from the gastrointestinal tract
PATIENT CHARACTERISTICS: Age
- 61 to 80
Performance status
- ECOG 0-2 OR
- Karnofsky 60-100%
Life expectancy
- Not specified
Hematopoietic
- WBC at least 2,500/mm^3
- Platelet count at least 100,000/mm^3
Hepatic
- Bilirubin no greater than 2 times upper limit of normal (ULN)
- No active hepatitis infection
Renal
- Creatinine no greater than 2 times ULN
Cardiovascular
- No Canadian Cardiovascular Society class III or IV angina pectoris
- No New York Heart Association class III or IV cardiac failure
- Ejection fraction at least 50%
- Fractional shortenings at least 25% by echocardiography or nuclear medicine examination
Pulmonary
- FEV1 at least 50%
- Diffusion capacity at least 50%
Other
- No uncontrolled diabetes mellitus
- No known hypersensitivity to any study medications
- No other concurrent malignancy
- HIV negative
PRIOR CONCURRENT THERAPY: Biologic therapy
- Not specified
Chemotherapy
- No prior chemotherapy
Endocrine therapy
- Not specified
Radiotherapy
- No prior radiotherapy
Surgery
- Not specified
Other
- Must not have already initiated lymphoma therapy (except for the prephase treatment specified for this study)
- No other concurrent lymphoma therapy
- No concurrent participation in another treatment study
Location and Contact Information
Germany
Leipzig, D-04103, Germany; Recruiting
Allgemeines Krankenhaus Altona, Hamburg, 22763, Germany; Recruiting
Allgemeines Krankenhaus Hagen, Hagen, 58095, Germany; Recruiting
Minden, D-32427, Germany; Recruiting
Augsburg, 86150, Germany; Recruiting
Buergerhospital Stuttgart, Stuttgart, 70191, Germany; Recruiting
Caritas - Krakenhaus Lebach, Lebach, 66822, Germany; Recruiting
Caritasklinik St. Theresia, Saarbrucken, 66113, Germany; Recruiting
Carl - Thiem - Klinkum Cottbus, Cottbus, 03048, Germany; Recruiting
Centre for Internal Medicine Gieben, Gieben, 35392, Germany; Recruiting
Deaconess Hospital, Schwabisch Hall, 74523, Germany; Recruiting
Deutsche Klinik fuer Diagnostik, Wiesbaden, 65191, Germany; Recruiting
Diakonissen-Krankenhaus Stuttgart, Stuttgart, 70176, Germany; Recruiting
Dr. Horst-Schmidt-Kliniken, Wiesbaden, 65199, Germany; Recruiting
Dreifaltigkeits Hospital, Lippstadt, 59555, Germany; Recruiting
Ernst-Moritz-Arndt University, Greifswald, 17489, Germany; Recruiting
Ev. Diakome Krankenhaus gGmBH, Bremen, 28239, Germany; Recruiting
Ev. Hospital Bethesda, Monchengladbach, 41061, Germany; Recruiting
Ev. Hospital Oldenburg, Oldenburg, 26122, Germany; Recruiting
Ev. Hospital Unna, Unna, 59403, Germany; Recruiting
Ev. Hospital Witten-Herdecke, WITTEN, 58455, Germany; Recruiting
Ev. Hospital, Mulheim/Ruhr, 45466, Germany; Recruiting
Evang. Deaconess Hospital Freiburg, Freiburg, 79110, Germany; Recruiting
Evang. Hospital, Holzminden, 37603, Germany; Recruiting
Evang. Jung-Stilling Hospital, Siegen, 57074, Germany; Recruiting
Evang. Stift St. Martin gGmbH Koblenz, Koblenz, 56068, Germany; Recruiting
Evangelische Krankenhaus Hamm, Hamm, 59063, Germany; Recruiting
Evangelisches Krankenhaus Essen Werden, Essen-Werden, 45239, Germany; Recruiting
Florence-Nightingale-Krankenhause, Deaconess Kaiserswerth, Dusseldorf, 40489, Germany; Recruiting
Frankenwald Klinik, Kronach, 96317, Germany; Recruiting
Franz Hospital Dulmen, Dulmen, 48249, Germany; Recruiting
Hannover, 30159, Germany; Recruiting
Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie, Ansbach, 91522, Germany; Recruiting
Gemeinschaftspraxis Innere Medizin, Jena, D-07743, Germany; Recruiting
General Hospital, CELLE, 29223, Germany; Recruiting
Monchenglasbach/Rheydt, D-41239, Germany; Recruiting
Trier, D-54290, Germany; Recruiting
Haematologisch Onkologische Praxis, Aachen, 52070, Germany; Recruiting
Haematologische Praxis, Augsburg, 86150, Germany; Recruiting
Haematologisch-Onkologische Praxis Altona, Hamburg, D-22767, Germany; Recruiting
Haematologisch-Onkologische Schwerpunktpraxis, Berlin, 13357, Germany; Recruiting
Hans - Susemihl - Krankenhaus, Emden, 26721, Germany; Recruiting
Hematologische Onkologische Praxis, Regensburg, 93047, Germany; Recruiting
Hematologische Praxis, Oldenburg, 26121, Germany; Recruiting
Hospital Altstadt Magdeburg, Magdeburg, 39104, Germany; Recruiting
Hospital Bad Cannstatt, Stuttgart, 70374, Germany; Recruiting
Hospital Complex Bernburg, Bernburg, 06406, Germany; Recruiting
Hospital Complex Hoyerswerda, Hoyerswerda, 02977, Germany; Recruiting
Hospital Complex North, Heidberg, Hamburg, 22413, Germany; Recruiting
Hospital Complex of the University Regensburg, Regensburg, 93042, Germany; Recruiting
Hospital Kuchwald Chemnitz, Chemnitz, 09113, Germany; Recruiting
Hospital Maria-Hilf II, Monchengladbach, 41063, Germany; Recruiting
Hospital Neunkirchen gGmbH, Neunkirchen, 66538, Germany; Recruiting
Hospital Tutzing, Tutzing, 82327, Germany; Recruiting
Hospital Wetzler, Wetzlar, 35578, Germany; Recruiting
Humaine - Clinic, Bad Saarow, 15523, Germany; Recruiting
II. Medizinische Klinik, Aschaffenburg, 63739, Germany; Recruiting
III Medizinische Klinik Mannheim, Mannheim, D-68305, Germany; Recruiting
Jakobi Krankenhaus, Rheine, 48431, Germany; Recruiting
Johannes Gutenberg University, Mainz, 55131, Germany; Recruiting
Klinik fuer Onkologie - Katharinenhospital Stuttgart, Stuttgart, 70174, Germany; Recruiting
Klinik und Poliklinik fuer Innere Medizin - Universitaet Rostock, Rostock, 18057, Germany; Recruiting
Klinik und Poliklinik fuer Strahlentherapie - Universitaetsklinikum Rostock, Rostock, 18059, Germany; Recruiting
Kliniken St. Antonius, Wuppertal, 42283, Germany; Recruiting
Klinikum Darmstadt, Darmstadt, 64283, Germany; Recruiting
Klinikum der Friedrich-Schiller Universitaet Jena, Jena, 07747, Germany; Recruiting
Klinikum Erfurt, Erfurt, 99089, Germany; Recruiting
Klinikum Ernst Von Bergmann, Potsdam, 14467, Germany; Recruiting
Klinikum Frankfurt, Frankfurt/Oder, 15236, Germany; Recruiting
Klinikum Grosshadern der Ludwig-Maximilians Universitaet Muenchen, Munich, 81377, Germany; Recruiting
Klinikum Krefeld GmbH, Krefeld, 47805, Germany; Recruiting
Klinikum Krollwitz, Halle, 06120, Germany; Recruiting
Klinikum Lippe - Lemgo, LEMGO, 32657, Germany; Recruiting
Klinikum Ludwigsburg, Ludwigsburg, 71640, Germany; Recruiting
Klinikum Minden, Minden, 32423, Germany; Recruiting
Klinikum Nuernberg - Klinikum Nord, Nuremberg, 90340, Germany; Recruiting
Klinikum Offenburg, Offenburg, 77654, Germany; Recruiting
Klinikum Oldenburg, Oldenburg, 26133, Germany; Recruiting
Klinikum St. Marien, Amberg, 92224, Germany; Recruiting
Knappschaft Krankenhaus, Bochum, 44892, Germany; Recruiting
Krankenhaus Bietigheim, Bietigheim, 74321, Germany; Recruiting
Krankenhaus D Barmherzigen Brueder, Regensburg, 93049, Germany; Recruiting
Krankenhaus der Barmherzigen Brueder, Trier, 54292, Germany; Recruiting
Krankenhaus Hohe Warte Mediziniche Klinik, Bayreuth, 95445, Germany; Recruiting
Krankenhaus Nordwest, Frankfurt, 60488, Germany; Recruiting
Krankenhaus Siloah - Medizinische Klinik II, Hannover, 30449, Germany; Recruiting
Kreiskrankenhaus Aurich, Aurich, 26603, Germany; Recruiting
Kreiskrankenhaus Radebeul, Radebeul, 01445, Germany; Recruiting
Kreiskrankenhaus, Herford, 32049, Germany; Recruiting
Rostock, D-18257, Germany; Recruiting
Leonardis Clinic, Kornwestheim, 70806, Germany; Recruiting
Leopoldina - Krankenhaus, Schweinfurt, 97422, Germany; Recruiting
Lukaskrankenhaus Neuss, Neus, 41464, Germany; Recruiting
Lung Clinic Cologne-Merheim, Cologne-Merheim, 51109, Germany; Recruiting
Cologne-Kalk, D-51105, Germany; Recruiting
Marienhospital / Ruhr University Bochum, Herne, 44625, Germany; Recruiting
Marienhospital, Vechta, 49377, Germany; Recruiting
Martin - Luther Hospital, Schleswig, 24837, Germany; Recruiting
Medical University Hospital Homburg, Homburg, 66421, Germany; Recruiting
Medical University of Lubeck, Lubeck, 23538, Germany; Recruiting
Medizinische Hochschule Hannover, Hannover, 30625, Germany; Recruiting
Medizinische Kl. Klinikum Innenstadt Universitaet Muenchen, Munich, 80336, Germany; Recruiting
Medizinische Klinik Am Lukas - Krankenhaus, Bunde, 32257, Germany; Recruiting
Medizinische Klinik I, Dresden, 01307, Germany; Recruiting
Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster, Munster, 48129, Germany; Recruiting
Medizinische Poliklinik, Bonn, 53111, Germany; Recruiting
Medizinische Universitaetsklinik I, Cologne, 50924, Germany; Recruiting
Medizinische Universitaetsklinik und Poliklinik, Heidelberg, 69115, Germany; Recruiting
Medizinischen Klinik Dr. R. Schindlbeck, Herrsching, 82211, Germany; Recruiting
Munich Oncologic Practice at Elisenhof, Munich, 80335, Germany; Recruiting
Municipal Complex of Ludwigshafen, Ludwigshafen, 67063, Germany; Recruiting
Municipal Hospital Complex of the University, Kaiserslautern, 67655, Germany; Recruiting
Municipal Hospital Complex Zwickau, Zwickau, 08060, Germany; Recruiting
Municipal Hospital Complex, Villingen-Schwenningen, 78045, Germany; Recruiting
Municipal Hospital Complex, Pforzheim, 75175, Germany; Recruiting
Municipal Hospital Complex, Fulda, 36043, Germany; Recruiting
Municipal Hospital Munich Schwarbing, Munich, 80804, Germany; Recruiting
Municipal Hospital Munich, Munich, 81737, Germany; Recruiting
Mutterhaus der Borromaerinnen, Trier, 54290, Germany; Recruiting
Neurologische Klinik - Henriettenstiftung, Hannover, 30559, Germany; Recruiting
Oncological Specialist Practice, Harrislee, 24955, Germany; Recruiting
Oncological Specialist Practice, Hildesheim, 31134, Germany; Recruiting
Paracelsus - Clinic Osnabruck, Osnabruck, 49076, Germany; Recruiting
Philipps-Universitaet Marburg Klinikum, Marburg, 35043, Germany; Recruiting
Praxis Fuer Haematologie Internistische Onkologie, Koeln, D-50677, Germany; Recruiting
Praxis fuer Haematologie und Onkologie, Koblenz, D-56068, Germany; Recruiting
Red Cross Hospital Kassel, Kassel, 34121, Germany; Recruiting
Regional Hospital Am Plattenwald, Bad Friedrichshall, 74172, Germany; Recruiting
Regional Hospital Bad Hersfeld, Bad Hersfeld, 36251, Germany; Recruiting
Regional Hospital Heidenheim, Heidenheim, 89522, Germany; Recruiting
Regional Hospital Mayen, Mayen, 56727, Germany; Recruiting
Regional Hospital Munchberg, Munchberg, 95213, Germany; Recruiting
Regional Hospital Neumarkt, Neumarkt, 92318, Germany; Recruiting
Regional Hospital Traunstein, Traunstein, 83278, Germany; Recruiting
Regional Hospital Waldbrol, Waldbrol, 51545, Germany; Recruiting
Rheinische Friedrich-Wilhelms-Universitat, Bonn, D-53113, Germany; Recruiting
Robert - Koch Hospital, Gehrden, 30989, Germany; Recruiting
Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch, Berlin, 13125, Germany; Recruiting
Robert-Bosch-Krankenhaus, Stuttgart, 70376, Germany; Recruiting
Saint Agnes Hospital, Bocholt, 46397, Germany; Recruiting
Saint Elisabeth / Saint Barbara Hospital, Halle/Saale, 06110, Germany; Recruiting
Saint Johannes Hospital Dortmund, Dortmund, 44137, Germany; Recruiting
Saint Josef Hospital, Bochum, 44791, Germany; Recruiting
Schwerpunktpraxis Fuer Haematologie Und Onkologie, Saarbruecke, N-66113, Germany; Recruiting
Specialist Practice for Oncology, Aschaffenburg, 63739, Germany; Recruiting
St. Antonius Hospital, Eschweiler, 52249, Germany; Recruiting
St. Bonifatius Hospital Lingen, Lingen, 49808, Germany; Recruiting
St. Elisabeth Hospital Ravensburg, Ravensburg, 88212, Germany; Recruiting
St. Elisabeth Hospital Thuine, Thuine, 49832, Germany; Recruiting
St. Elisabeth Hospital, Saarlouis, 66713, Germany; Recruiting
St. Johannes Hospital - Medical Klinik II, Duisburg, 47166, Germany; Recruiting
St. Lukas - Clinic Solingen, Solingen, 42697, Germany; Recruiting
St. Marien Hospital - Muelheim an der Ruhr, Mulheim/Ruhr, 45468, Germany; Recruiting
St. Marien Hospital at Katholisches Krankenhaus hagen gem. GmbH, Hagen, 58095, Germany; Recruiting
St. Marien Hospital Ludwighafen, Ludwigshafen, 67067, Germany; Recruiting
St. Vincenz Hospital Limburg, Limburg, 65549, Germany; Recruiting
Stadisches Krankenhaus Martha Maria Halle-Dolau, Halle, 06120, Germany; Recruiting
Stadt Krankenhaus Gutersloh, Gutersloh, 33332, Germany; Recruiting
Staedt Klinikum Karlsruhe GGMBH, Karlsruhe, 76133, Germany; Recruiting
Staedtische Krankenhaus Kiel, Kiel, 23116, Germany; Recruiting
Staedtisches Klinikum "St. Georg" Leipzig, Leipzig, 04129, Germany; Recruiting
Thoraxklinik Heidelberg, Heidelberg, 69126, Germany; Recruiting
Universitaetsklinikum Essen, ESSEN, 45147, Germany; Recruiting
Universitaetsklinikum Goettingen, Gottingen, 37075, Germany; Recruiting
Universitaetsklinikum Ulm, Ulm, 89081, Germany; Recruiting
Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg, Magdeburg, 39120, Germany; Recruiting
Universitaets-Krankenhaus Eppendorf, Hamburg, 20251, Germany; Recruiting
University Leipzig Clinic of Internal Medicine, Leipzig, 04103, Germany; Recruiting
University Wurzburg, Wurzburg, 97070, Germany; Recruiting
Marburg, D-35037, Germany; Recruiting
Hamburg, 20095, Germany; Recruiting
Zentralklinikum Augsburg, Augsburg, 86156, Germany; Recruiting
Switzerland
City Hospital Triemli, Zurich, 8063, Switzerland; Recruiting
UniversitaetsSpital, Zurich, 8091, Switzerland; Recruiting
Michael G.M. Pfreundschuh, MD, Study Chair, Universitatsklinik - Saarland
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: December 2002
Last Updated: January 6, 2005
Record first received: January 24, 2003
ClinicalTrials.gov Identifier: NCT00052936
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


